Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): Clinicopathologic and immunohistochemical analysis of 123 cases

American Journal of Surgical Pathology

Volumn 36, Issue 9, 2012, Pages 1279-1301

  Adsay, Volkan ^a   Jang, Kee Taek ^b   Roa, Juan Carlos ^c   Dursun, Nevra ^d   Ohike, Nobuyuki ^e   Bagci, Pelin ^f   Basturk, Olca ^g   Bandyopadhyay, Sudeshna ^h   Cheng, Jeanette D ⁱ   Sarmiento, Juan M ^d   Escalona, Oscar Tapia ^c   Goodman, Michael ^j   Kong, So Yeon ^j   Terry, Paul ^k  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c UNIVERSIDAD DE LA FRONTERA   (Chile)

^d Istanbul Education and Research Hospital ^*  (United States)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j EMORY UNIVERSITY   (United States)

^k UNIVERSITY OF TENNESSEE   (United States)

more..

Author keywords

adenoma; biliary; carcinoma; gallbladder; in situ; intestinal; oncocytic; papillary; preinvasive neoplasm; pyloric; tubular

Indexed keywords

MUCIN; TUMOR MARKER;

ADENOCARCINOMA; ADENOMA; AGED; ARTICLE; CANCER INVASION; CELL LINEAGE; DISEASE COURSE; FEMALE; GALLBLADDER; GALLBLADDER TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; POLYP;

ADENOCARCINOMA; ADENOCARCINOMA, PAPILLARY; ADENOMA; AGED; CELL LINEAGE; DISEASE PROGRESSION; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCINS; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; POLYPS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865500469     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318262787c     Document Type: Article

References (171)

1. Albores-Saavedra J, Adsay NV, Crawford JM, et al. Carcinoma of the gallbladder and extrahepatic bile ducts. In: Bosman FT, Carneiro F, Hruban R, et al, eds. World Health Organization Classification of Tumors Tumors of Digestive System. 4th ed. Lyon: IARC Press; 2010:266-274.
2. Adsay N, Fukushima N, FukayamaM, et al. Intraductal neoplasms of the pancreas. In: Bosman F, Carneiro F, Hruban R, et al, eds. World Health Organization Classification of Tumors Tumors of Digestive Systemedn, Vol. Lyon: IARC Press; 2010:304-313.
3. Bedenne L, Faivre J, Boutron MC, et al. Adenoma-carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer. 1992;69:883-888.
4. Chen CD, Yen MF, Wang WM, et al. A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer. 2003;88: 1866-1873.
5. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ. 2004;157:327-349.
6. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
7. Hermanek PJ Jr., Giedl J. The adenoma-carcinoma sequence in AMMN-induced colonic tumors of the rat. Pathol Res Pract. 1984;178:548-554. (Pubitemid 14030279)
8. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425: 357-367.
9. Milchgrub S, Campuzano M, Casillas J, et al. Intraductal carcinoma of the pancreas. Cancer. 1992;69:651-656.
10. Adsay NV, Conlon KC, Zee SY, et al. Intraductal papillarymucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer. 2002;94:62-77. (Pubitemid 34049043)
11. Aldridge MC, Bismuth H. Gallbladder cancer: the polyp-cancer sequence. Br J Surg. 1990;77:363-364. (Pubitemid 20119365)
12. Suzuki A, Takahashi T. Histogenesis of the gallbladder carcinoma induced by methylcholanthrene beeswax pellets in hamsters. Jpn J Surg. 1983;13:55-59. (Pubitemid 14244727)
13. Kozuka S, Tsubone N, Yasui A, et al. Relation of adenoma to carcinoma in the gallbladder. Cancer. 1982;50:2226-2234. (Pubitemid 13203636)
14. Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathology. 2009;55:218-229.
15. Lee SH, Lee DS, You IY, et al. Histopathologic analysis of adenoma and adenoma-related lesions of the gallbladder. Korean J Gastroenterol. 2010;55:119-126.
16. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, et al. Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol. 2010;28:401-408.
17. Hodges KB, Lopez-Beltran A, Davidson DD, et al. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. Hum Pathol. 2010;41:155-162.
18. Cheng L, Davidson DD, Maclennan GT, et al. The origins of urothelial carcinoma. Expert Rev Anticancer Ther. 2010;10:865-880.
19. Pai RK, Mojtahed K. Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas. Appl Immunohistochem Mol Morphol. 2011;19:133-140.
20. Abraham SC, Lee JH, Hruban RH, et al. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol. 2003;34:902-910. (Pubitemid 37169620)
21. Adsay NV, Adair CF, Heffess CS, et al. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol. 1996; 20:980-994. (Pubitemid 26250638)
22. Abraham SC, Lee JH, Boitnott JK, et al. Microsatellite instability in intraductal papillary neoplasms of the biliary tract. Mod Pathol. 2002;15:1309-1317. (Pubitemid 35462999)
23. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28:839-848. (Pubitemid 38856838)
24. Basturk O, Coban I, Adsay NV. Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med. 2009;133:423-438.
25. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799. (Pubitemid 41728866)
26. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas, Vol. 6. Washington, DC: American Registry of Pathology; 2007.
27. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987. (Pubitemid 38971421)
28. Klimstra DS, Adsay NV, Odze RD, et al. Tumors of the pancreas and ampulla vater. In: Odze R, Goldblum J, eds. Surgical Pathology of the GI tract, Liver, Biliary Tract, and Pancreasedn, Vol. Philadelphia: Elsevier. 2009:909-960.
29. Luttges J, Zamboni G, Longnecker D, et al. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001;25:942-948. (Pubitemid 32594989)
30. Rouzbahman M, Serra S, Adsay NV, et al. Oncocytic papillary neoplasms of the biliary tract: a clinicopathological, mucin core and Wnt pathway protein analysis of four cases. Pathology. 2007;39:413-418. (Pubitemid 47221475)
31. Shibahara H, Tamada S, Goto M, et al. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2004;28:327-338. (Pubitemid 38269566)
32. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
33. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Ampulla of Vater. Atlas of Tumor Pathology, 3rd Edition, 3 edn, Vol. 27. Washington D.C.: Armed Forces Institute of Pathology; 2000.
34. Sadakari Y, Ohuchida K, Nakata K, et al. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery. 2010;147:812-817.
35. Klö ppel G, Hruban R, Longnecker DS, et al. Ductal adenocarcinoma of the pancreas. In: Hamilton S, Aaltonen L, eds. World Health Organization Classification of Tumors Tumors of Digestive Systemedn, Vol. Lyon: IARC Press; 2000:219-230.
36. Amaris J. Intraductal mucinous papillary tumor and pyloric gland adenoma of the pancreas. Gastrointest Endosc. 2002;56:441-444.
37. Kato N, Akiyama S, Motoyama T. Pyloric gland-type tubular adenoma superimposed on intraductal papillary mucinous tumor of the pancreas. Pyloric gland adenoma of the pancreas. Virchows Arch. 2002;440:205-208. (Pubitemid 34169858)
38. Tajiri T, Tate G, Inagaki T, et al. Intraductal tubular neoplasms of the pancreas: histogenesis and differentiation. Pancreas. 2005;30:15-21.
39. Tajiri T, Tate G, Kunimura T, et al. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas. Pancreas. 2004;29:116-122. (Pubitemid 38971801)
40. Yamaguchi H, Shimizu M, Ban S, et al. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2009;33:1164-1172.
41. Klimstra D, Adsay NV, Dhall D, et al. Intraductal tubular carcinoma of the pancreas: clinicopathologic and immunohistochemical analysis of 18 cases. Mod Pathol. 2007;20:285A.
42. Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333-1343. (Pubitemid 44748384)
43. Oshikiri T, Kashimura N, Katanuma A, et al. Mucin-secreting bile duct adenoma-clinicopathological resemblance to intraductal papillary mucinous tumor of the pancreas. Dig Surg. 2002;19:324-327. (Pubitemid 35013745)
44. Lim JH, Jang KT, Rhim H, et al. Biliary cystic intraductal papillary mucinous tumor and cystadenoma/cystadenocarcinoma: differentiation by CT. Abdom Imaging. 2007;32:644-651. (Pubitemid 47594240)
45. Kim HJ, Kim MH, Lee SK, et al. Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy. 2000;32:389-393. (Pubitemid 30219156)
46. Kim H, Lim JH, Jang KT, et al. Morphology of intraductal papillary neoplasm of the bile ducts: radiologic-pathologic correlation. Abdom Imaging. 2011;36:438-446.
47. Kloek JJ, van der Gaag NA, Erdogan D, et al. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. Hum Pathol. 2011;42:824-832.
48. Ji Y, Fan J, Zhou J, et al. Intraductal papillary neoplasms of bile duct. A distinct entity like its counterpart in pancreas. Histol Histopathol. 2008;23:41-50.
49. Barton JG, Barrett DA, Maricevich MA, et al. Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? HPB (Oxford). 2009;11:684-691.
50. Kloppel G, Solcia E, Longnecker DS. Histologic Typing of Tumors of the Exocrine Pancreas, Vol. Geneva: Springer-Verlag; 1996.
51. Sudo Y, Harada K, Tsuneyama K, et al. Oncocytic biliary cystadenocarcinoma is a form of intraductal oncocytic papillary neoplasm of the liver. Mod Pathol. 2001;14:1304-1309. (Pubitemid 33151175)
52. Zalinski S, Paradis V, Valla D. Intraductal papillary mucinous tumors of both biliary and pancreatic ducts. J Hepatol. 2007;46:978-979. (Pubitemid 46529051)
53. Zen Y, Sasaki M, Fujii T. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol. 2006;44:350-358. (Pubitemid 43069217)
54. Ohike N, Kim GE, Tajiri T, et al. Intra-ampullary papillarytubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases. Am J Surg Pathol. 2010;34:1731-1748.
55. Yamamoto M, Nakajo S, Tahara E. Histological classification of epithelial polypoid lesions of the gallbladder. Acta Pathol Jpn. 1988;38:181-192. (Pubitemid 18089410)
56. Adsay NV, Klimstra DS. Benign and malignant tumors of the gallbladder and extrahepatic biliary tract. In: Odze RD, Goldblum JR, eds. Surgical Pathology of the GI tract, Liver, Biliary Tract, and Pancreasedn, Vol. Philadelphia: Elsevier; 2009:845-875.
57. Albores-Saavedra J, Tuck M, McLaren BK, et al. Papillary carcinomas of the gallbladder: analysis of noninvasive and invasive types. Arch Pathol Lab Med. 2005;129:905-909. (Pubitemid 40934310)
58. Albores-Saavedra J, Vardaman CJ, Vuitch F. Non-neoplastic polypoid lesions and adenomas of the gallbladder. Pathol Annu. 1993;28(pt 1):145-177.
59. Escalona A, Leon F, Bellolio F, et al. Gallbladder polyps: correlation between ultrasonographic and histopathological findings. Rev Med Chil. 2006;134:1237-1242.
60. Albores-Saavedra J, Henson DE. Gallbladder and Extrahepatic Bile Ducts. Philadelphia: W.B. Saunders; 1993:167-181.
61. Kato S. Morphological analysis of the gallbladder elevated lesions-macroscopic, stereoscopic, and histological study. Nippon Shokakibyo Gakkai Zasshi. 1995;92:1149-1160.
62. Laitio M. Early carcinoma of the gallbladder. Beitr Pathol. 1976;158:159-172.
63. Laitio M. Histogenesis of epithelial neoplasms of human gallbladder II. Classification of carcinoma on the basis of morphological features. Pathol Res Pract. 1983;178:57-66. (Pubitemid 14235786)
64. Liu ZH, Zhang XH. Morphological analysis of 40 polypoid lesions of the gallbladder and their clinical significance. Zhonghua Bing Li Xue Za Zhi. 1991;20:274-276.
65. Nagata S, Ajioka Y, Nishikura K, et al. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10. Oncol Rep. 2007;17:721-729.
66. Nakajo S, Yamamoto M, Tahara E. Morphometrical analysis of gall-bladder adenoma and adenocarcinoma with reference to histogenesis and adenoma-carcinoma sequence. Virchows Arch A Pathol Anat Histopathol. 1990;417:49-56. (Pubitemid 20180854)
67. Ono T, Masamune O. [Gallbladder adenoma (pyloric gland type, intestinal type, proper epithelial type, papillary type, mucinous cystic type]. Ryoikibetsu Shokogun Shirizu. 1996;9:308-310.
68. Roa I, de Aretxabala X, Morgan R, et al. Clinicopathological features of gallbladder polyps and adenomas. Rev Med Chil. 2004;132:673-679. (Pubitemid 40142936)
69. Tanous JH, Ilano PC, Cruz A. Adenoma of the gallbladder. J Int Coll Surg. 1960;34:298-301.
70. Yamagiwa H. Clinico-pathological study of gallbladder diseases-V. Adenoma of the gallbladder. Rinsho Byori. 1986;34:729-732.
71. Zhou MJ. Adenoma of the gallbladder-pathologic analysis of 14 cases. Zhonghua Zhong Liu Za Zhi. 1985;7:448-450.
72. Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol. 1970;90:423-432.
73. Roa I, de Aretxabala X, Araya JC, et al. Preneoplastic lesions in gallbladder cancer. J Surg Oncol. 2006;93:615-623. (Pubitemid 43855690)
74. Zhang ZX, Yin WH, Zhu ZY. Adenoma of the gallbladder and its canceration: an analysis of 88 cases. Zhonghua Wai Ke Za Zhi. 1994;32:400-402.
75. Roa JC, Katabi N, Adsay NV. Molecular pathology of liver diseases. In: Monga P, ed. Neoplasms of the Gallbladder edn, Vol. New York, NY: Springer; 2011:891-905.
76. Adsay NV. Sternberg's diagnostic surgical pathology. In: Mills SE, ed. Gallbladder, Extrahepatic Biliary Tree, and Ampulla., 5 edn, Vol. 2. Philadelphia: Lippincott Williams and Wilkins; 2010: 1600-1663.
77. Mayo C. Papillomas of the gallbladder. Collected papers of the Mayo Clinic. 1915:249.
78. Almagro UA. Diffuse papillomatosis of the gallbladder. Am J Gastroenterol. 1985;80:274-278. (Pubitemid 15098201)
79. Aoki Y, Okamura T, Kurimoto H, et al. Papilloma of the gallbladder. Am J Surg. 1976;131:614-617.
80. Araki T, Hihara T, Karikomi M, et al. Intraluminal papillary carcinoma of the gallbladder: prognostic value of computed tomography and sonography. Gastrointest Radiol. 1988;13:261-265.
81. Diaz-Plasencia J, Vilela Desposorio C, Rebaza-Iparraguirre H, et al. Polypoid lesions of the gallbladder. Rev Gastroenterol Peru. 1994; 14:22-26.
82. Egeberg RO, Van Orden MT, Kaplan L. Primary papillary adenocarcinoma of the fundus of the gallbladder. Ann West Med Surg. 1949;3:66-68.
83. Kane CF, Brown CH, Hoerr SO. Papilloma of the gallbladder; report of eight cases. Am J Surg. 1952;83:161-164.
84. Kushima R, Remmele W, Stolte M, et al. Pyloric gland type adenoma of the gallbladder with squamoid spindle cell metaplasia. Pathol Res Pract. 1996;192:963-969; discussion 70-71.
85. Nagahama M, Muto Y, Yamada M, et al. Villous adenoma of the gallbladder: a case report. Hepatogastroenterology. 1997;44:681-684. (Pubitemid 27281099)
86. Nishihara K, Yamaguchi K, Hashimoto H, et al. Tubular adenoma of the gallbladder with squamoid spindle cell metaplasia. Report of three cases with immunohistochemical study. Acta Pathol Jpn. 1991;41:41-45.
87. Sato H, Mizushima M, Ito J, et al. Sessile adenoma of the gallbladder. Reappraisal of its importance as a precancerous lesion. Arch Pathol Lab Med. 1985;109:65-69. (Pubitemid 15060872)
88. Wani Y, Notohara K, Fujisawa M. Aberrant expression of an "intestinal marker" Cdx2 in pyloric gland adenoma of the gallbladder. Virchows Arch. 2008;453:521-527.
89. Wistuba II, Miquel JF, Gazdar AF, et al. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol. 1999;30:21-25. (Pubitemid 29037389)
90. Ito H, Hann LE, D'Angelica M, et al. Polypoid lesions of the gallbladder: diagnosis and followup. J Am Coll Surg. 2009; 208:570-575.
91. Colecchia A, Larocca A, Scaioli E, et al. Natural history of small gallbladder polyps is benign: evidence from a clinical and pathogenetic study. Am J Gastroenterol. 2009;104:624-629.
92. Chijiiwa K, Tanaka M. Polypoid lesion of the gallbladder: indications of carcinoma and outcome after surgery for malignant polypoid lesion. Int Surg. 1994;79:106-109. (Pubitemid 24214000)
93. Terzi C, Sokmen S, Seckin S, et al. Polypoid lesions of the gallbladder: report of 100 cases with special reference to operative indications. Surgery. 2000;127:622-627. (Pubitemid 30399052)
94. Yang HL, Sun YG, Wang Z. Polypoid lesions of the gallbladder: diagnosis and indications for surgery. Br J Surg. 1992;79:227-229.
95. Aldouri AQ, Malik HZ, Waytt J, et al. The risk of gallbladder cancer from polyps in a large multiethnic series. Eur J Surg Oncol. 2009;35:48-51.
96. Jiron MI, Silva H, Whittle C, et al. Gallbladder polyps. 2d Consensus Workshop of the Chilean Hepatology Association. Rev Med Chil. 1994;122:1316-1317.
97. Shin SR, Lee JK, Lee KH, et al. Can the growth rate of a gallbladder polyp predict a neoplastic polyp? J Clin Gastroenterol. 2009;43:865-868.
98. Huang CS, Lien HH, Jeng JY, et al. Role of laparoscopic cholecystectomy in the management of polypoid lesions of the gallbladder. Surg Laparosc Endosc Percutan Tech. 2001;11:242-247.
99. Tsuchiya Y, Uchimura M. Collective review of 503 cases of small polypoid lesions (less than 20mm in maximum diameter) of the gallbladder: size distribution in various diseases and the depth of carcinomatous invasion. Nippon Shokakibyo Gakkai Zasshi. 1986;83:2086-2087.
100. Persley KM. Gallbladder polyps. Curr Treat Options Gastroenterol. 2005;8:105-108. (Pubitemid 40542116)
101. Itoi T, Watanabe H, Ajioka Y, et al. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathology international. 1996;46:333-340. (Pubitemid 26230954)
102. Kijima H, Watanabe H, Iwafuchi M, et al. Histogenesis of gallbladder carcinoma from investigation of early carcinoma and microcarcinoma. Acta Pathol Jpn. 1989;39:235-244. (Pubitemid 19156649)
103. Sasatomi E, Tokunaga O, Miyazaki K. Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings. J Hepatobiliary Pancreat Surg. 2000;7:556-567.
104. Roa J, Tapia O, Manterola C, et al. Rokitansky Aschoff sinus involvement in early gallbladder carcinoma (EGBC) as a prognostic factor: a concurrent cohort study of 190 EGBC. Mod Pathol. 2011;24:373A.
105. Shi C, Klein AP, Goggins M, et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res. 2009;15:7737-7743.
106. Park KW, Kim SH, Choi SH, et al. Differentiation of nonneoplastic and neoplastic gallbladder polyps 1 cm or bigger with multidetector row computed tomography. J Comput Assist Tomogr. 2010;34:135-139.
107. Lee JS, Lee KT, Jung JH, et al. Factors associated with malignancy in gallbladder polyps without gallbladder stone. Korean J Gastroenterol. 2008;52:97-105.
108. Cha BH, Hwang JH, Lee SH, et al. Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladder. W J Gastroenterol. 2011;17:2216-2222.
109. Cho JH, Park JY, Kim YJ, et al. Hypoechoic foci on EUS are simple and strong predictive factors for neoplastic gallbladder polyps. Gastrointest Endosc. 2009;69:1244-1250.
110. Gallahan WC, Conway JD. Diagnosis and management of gallbladder polyps. Gastroenterol Clin North Am. 2010;39: 359-367, x.
111. Kwon W, Jang JY, Lee SE, et al. Clinicopathologic features of polypoid lesions of the gallbladder and risk factors of gallbladder cancer. J Korean Med Sci. 2009;24:481-487.
112. Matos AS, Baptista HN, Pinheiro C, et al. Gallbladder polyps: how should they be treated and when? Rev Assoc Med Bras. 2010;56:318-321.
113. Myers RP, Shaffer EA, Beck PL. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol. 2002; 16:187-194. (Pubitemid 34546294)
114. Vance C, Roa JC, Dursun N, et al. Non-neoplastic polyps of the gallbladder: incidence, histologic types, and clinicopathologic associations in an analysis of 162 cases. Mod Pathol. 2011;24:375A.
115. Fernandez-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2010; 139:708-713, 13 e1-2.
116. Adsay NV, Basturk O, Cheng JD, et al. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Semin Radiat Oncol. 2005;15:254-264. (Pubitemid 41377141)
117. Le Baleur Y, Couvelard A, Vullierme MP, et al. Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high-risk lesions. Pancreatology. 2011;11:495-499.
118. Takeshita A, Kimura W, Hirai I, et al. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma. Pancreas. 2012;41:114-120.
119. Park J, Sun D, Genest DR, et al. Coexistence of low and high grade squamous intraepithelial lesions of the cervix: morphologic progression or multiple papillomaviruses? Gynecol Oncol. 1998; 70:386-391. (Pubitemid 28473639)
120. Lee KR, Minter LJ, Crum CP. Koilocytotic atypia in Papanicolaou smears. Reproducibility and biopsy correlations. Cancer. 1997;81:10-15. (Pubitemid 28275321)
121. Amin MB, McKenney JK. An approach to the diagnosis of flat intraepithelial lesions of the urinary bladder using the World Health Organization/International Society of Urological Pathology consensus classification system. Adv Anat Pathol. 2002;9:222-232.
122. Abraham SC, Park SJ, Lee JH, et al. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol. 2003;16:786-795. (Pubitemid 37011074)
123. Abraham SC, Montgomery EA, Singh VK, et al. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol. 2002;26:1276-1285.
124. Chen ZM, Scudiere JR, Abraham SC, et al. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma. Am J Surg Pathol. 2009;33:186-193.
125. Levi E, Klimstra DS, Andea A, et al. MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol. 2004;57:456-462. (Pubitemid 38621788)
126. Yonezawa S, Taira M, Osako M, et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int. 1998;48:319-322. (Pubitemid 28328315)
127. Yonezawa S, Nakamura A, Horinouchi M. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg. 2002;9: 328-341. (Pubitemid 34993681)
128. Yonezawa S, Goto M, Yamada N, et al. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics. 2008;8: 3329-3341.
129. Adsay NV, Merati K, Nassar H, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol. 2003;27:571-578. (Pubitemid 36514469)
130. Basturk O, Khayyata S, Klimstra DS, et al. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am J Surg Pathol. 2010;34:364-370.
131. Tamada S, Goto M, Nomoto M, et al. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol Int. 2002;52: 713-723. (Pubitemid 35472026)
132. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol. 2001;25:26-42. (Pubitemid 32001830)
133. Li MK, Folpe AL. CDX-2 a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Pathol. 2004;11:101-105.
134. Moskaluk CA, Zhang H, Powell SM, et al. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. 2003;16:913-919. (Pubitemid 37152021)
135. Werling RW, Yaziji H, Bacchi CE, et al. a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303-310. (Pubitemid 36245795)
136. Ji H, Isacson C, Seidman JD, et al. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol. 2002;21:391-400.
137. Zhang H, Maitra A, Tabaczka P, et al. Differential MUC1, MUC2 and MUC5AC expression in colorectal, ampullary and pancreatobiliary carcinomas: potential biologic and diagnostic implications. Mod Pathol. 2003;16:138A.
138. Basturk O, Farris AB, Adsay NV. Immunohistology of pancreas, gallbladder, extrahepatic bile ducts, ampulla and liver. In: Dabbs D, ed. Diagnostic Immunohistochemistry. 3rd ed. Philadelphia: Saunders Elsevier; 2010:541-592.
139. Lee H, Rocha F, Klimstra D, et al. Intraductal papillary neoplasm of the bile duct (IPN): clinicopathologic study of 39 cases in comparison to pancreatic intraductal papillary mucinous neoplasm (IPMN) in a single North American institution (2001). Mod Pathol. 2011;24:367A.
140. Martin RC, Klimstra DS, Schwartz L, et al. Hepatic intraductal oncocytic papillary carcinoma. Cancer. 2002;95:2180-2187. (Pubitemid 35253380)
141. Tanaka M, Fukushima N, Noda N, et al. Intraductal oncocytic papillary neoplasm of the bile duct: clinicopathologic and immunohistochemical characteristics of 6 cases. Hum Pathol. 2009;40:1543-1552.
142. Cathro HP, Stoler MH. Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am J Clin Pathol. 2002;117:944-951. (Pubitemid 34564352)
143. Duval JV, Savas L, Banner BF. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder. Arch Pathol Lab Med. 2000;124:1196-1200. (Pubitemid 30650322)
144. Goldstein NS, Bassi D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Am J Clin Pathol. 2001;115:695-702. (Pubitemid 33051536)
145. Lee MJ, Lee HS, Kim WH, et al. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol. 2003;16:403-410. (Pubitemid 36618459)
146. Rullier A, Le Bail B, Fawaz R, et al. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol. 2000;24:870-876. (Pubitemid 30366276)
147. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
148. Akiyama T, Sahara H, Seto K, et al. Gallbladder cancer associated with cholesterosis. J Gastroenterol. 1996;31:470-474. (Pubitemid 26181809)
149. Shimada K, Yamamoto J, Kosuge T, et al. Adenocarcinoma confined to a cholesterol polyp of the gallbladder. Am J Gastroenterol. 1999;94:2568-2569. (Pubitemid 29420693)
150. Yoshikawa K, Yamamoto S, Ishizaki M, et al. A case of gallbladder adenoma based on cholesterol polyp. Nihon Shokakibyo Gakkai Zasshi. 1994;91:1365-1368.
151. Dursun N, Roa J, Tapia O, et al. Metaplasia in the gallbladder: an analysis of clinicopathologic associations in 1218 cholecystectomies. Mod Pathol. 2011;24:147A.
152. Furukawa T, Hatori T, Fujita I, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:509-516.
153. Unger P, Perino G, Schiff H, et al. Eosinophilic globules resembling mallory bodies in a renal cell carcinoma. N Y State J Med. 1992;92:18-20.
154. Kloppel G, Kosmahl M. Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm? J Hepatol. 2006;44:249-250. (Pubitemid 43069204)
155. Hennessey D, Barry M, Maguire D. Polypoid lesions of the gallbladder: does size matter? Ann Surg. 2008;248:1110-1111.
156. Watanabe H, Date K, Itoi T, et al. Histological and genetic changes in
157. Higuchi R, Watanabe F, Horio Y, et al. A huge polypoid early gallbladder carcinoma with wide mucosal spreading. Nippon Shokakibyo Gakkai Zasshi. 2000;97:209-212. (Pubitemid 30145811)
158. Zhang XH. Polypoid lesions of the gallbladder. Clinical and pathological correlations. Zhonghua Wai Ke Za Zhi. 1991;29:211-213, 69.
159. Donohue JH, Stewart AK, Menck HR. The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995. Cancer. 1998;83:2618-2628. (Pubitemid 29019584)
160. Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485-489.
161. Poultsides GA, Reddy S, Cameron JL, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010;251:470-476.
162. Ban S, Yamaguchi H, Shimizu M. Pancreatic intraductal lesions with possible relationship with gastric type intraductal papillary mucinous neoplasm: pyloric gland-type intraductal tubular adenoma and intraductal oncocytic papillary neoplasm. Histopathology. 2010;56:968-969. Author reply 9.
163. Nakatani Y, Masudo K, Nozawa A, et al. Biotin-rich, optically clear nuclei express estrogen receptor-beta: tumors with morules may develop under the influence of estrogen and aberrant betacatenin expression. Hum Pathol. 2004;35:869-874. (Pubitemid 38903081)
164. Jang KT, Dursun N, Basturk O, et al. Immunohistochemical analysis of the progression of flat versus tumoral intraepithelial neoplasia (intracholecysitc papillary-tubular neoplasm) in gallbladder carcinogenesis. Mod Pathol. 2011;24:363A.
165. Ban S, Naitoh Y, Mino-Kenudson M, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol. 2006;30: 1561-1569. (Pubitemid 44808792)
166. Grutzmann R, Niedergethmann M, Pilarsky C, et al. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist. 2010;15:1294-1309.
167. Gourgiotis S, Ridolfini MP, Germanos S. Intraductal papillary mucinous neoplasms of the pancreas. Eur J Surg Oncol. 2007; 33:678-684. (Pubitemid 47029667)
168. Tanaka M. Intraductal papillary mucinous neoplasm of the pancreas: diagnosis and treatment. Pancreas. 2004;28:282-288. (Pubitemid 38437324)
169. Takasu N, Kimura W, Moriya T, et al. Intraductal papillarymucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type. Pancreas. 2010;39:604-610.
170. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500-1507. (Pubitemid 35231650)
171. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788-797; discussion 97-99.